Drug Type CAR-NK |
Synonyms- |
Target |
Action modulators |
Mechanism CXCR2 modulators(C-X-C motif chemokine receptor 2 modulators), ROR1 modulators(Inactive tyrosine-protein kinase transmembrane receptor ROR1 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Ewing Sarcoma | Preclinical | - | - | 04 Feb 2026 |





